Apatinib as Salvage Therapy for Heavily Pretreated SCLC

Apatinib as Salvage Therapy for Heavily Pretreated SCLC

Small cell lung cancer (SCLC) was highly malignant and lack effective treatment after the failure of radiotherapy and chemotherapy. Antiangiogenic therapy had shown a certain effect in advanced SCLC. Apatinib, a new potent oral small-molecule tyrosine kinase inhibitor targeting the intracellular dom...

Full description

Bibliographic Details
Main Authors: Fangfang LI, Haitao TAO
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2018-07-01
Series:Chinese Journal of Lung Cancer
Subjects:
Small cell lung cancer
Angiogenesis
Apatinib
Gilbert syndrome
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2018.07.11

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2018.07.11

Similar Items